<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">sibmed</journal-id><journal-title-group><journal-title xml:lang="ru">Сибирский научный медицинский журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Сибирский научный медицинский журнал</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2410-2512</issn><issn pub-type="epub">2410-2520</issn><publisher><publisher-name>ИЦиГ СО РАН</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/SSMJ20240208</article-id><article-id custom-type="elpub" pub-id-type="custom">sibmed-1461</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕДИКО-БИОЛОГИЧЕСКИЕ НАУКИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOMEDICINE</subject></subj-group></article-categories><title-group><article-title>Сравнительная оценка гемосовместимости шовного материала, модифицированного гепарином с помощью разных методик</article-title><trans-title-group xml:lang="en"><trans-title>Comparative assessment of hemocompatibility of the suture material modified with heparin using different techniques</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0033-9376</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Акентьева</surname><given-names>Т. Н.</given-names></name><name name-style="western" xml:lang="en"><surname>Akentieva</surname><given-names>Т. N.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Акентьева Татьяна Николаевна</p><p>650002, г. Кемерово, б-р им. Академика Л.С. Барбараша, 6</p></bio><bio xml:lang="en"><p>Tatyana N. Akentieva</p><p>650002, Kemerovo, Academician Barbarash blvd., 6</p></bio><email xlink:type="simple">t.akentyeva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7259-9089</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лузгарев</surname><given-names>С. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Luzgarev</surname><given-names>S. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лузгарев Сергей Валентинович, к.х.н.</p><p>650000, г. Кемерово, ул. Красная, 6</p></bio><bio xml:lang="en"><p>Sergey V. Luzgarev, candidate of chemical sciences</p><p>650000, Kemerovo, Krasnaya st., 6</p></bio><email xlink:type="simple">polymer@kemsu.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4890-0393</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Глушкова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Glushkova</surname><given-names>Т. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Глушкова Татьяна Владимировна, к.б.н.</p><p>650002, г. Кемерово, б-р им. Академика Л.С. Барбараша, 6</p></bio><bio xml:lang="en"><p>Tatyana V. Glushkova, candidate of biological sciences</p><p>650002, Kemerovo, Academician Barbarash blvd., 6</p></bio><email xlink:type="simple">bio.tvg@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6134-7468</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кудрявцева</surname><given-names>Ю. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kudryavtseva</surname><given-names>Yu. А.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кудрявцева Юлия Александровна, д.б.н.</p><p>650002, г. Кемерово, б-р им. Академика Л.С. Барбараша, 6</p></bio><bio xml:lang="en"><p>Yulia A. Kudryavtseva, doctor of biological sciences</p><p>650002, Kemerovo, Academician Barbarash blvd., 6</p></bio><email xlink:type="simple">kudryavtseva_yulia@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>НИИ комплексных проблем сердечно-сосудистых заболеваний</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Research Institute for Complex Issues of Cardiovascular Diseases</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Кемеровский государственный университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Kemerovo State University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>04</month><year>2024</year></pub-date><volume>44</volume><issue>2</issue><fpage>64</fpage><lpage>72</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Акентьева Т.Н., Лузгарев С.В., Глушкова Т.В., Кудрявцева Ю.А., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Акентьева Т.Н., Лузгарев С.В., Глушкова Т.В., Кудрявцева Ю.А.</copyright-holder><copyright-holder xml:lang="en">Akentieva Т.N., Luzgarev S.V., Glushkova Т.V., Kudryavtseva Y.А.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://sibmed.elpub.ru/jour/article/view/1461">https://sibmed.elpub.ru/jour/article/view/1461</self-uri><abstract><p>Проблема послеоперационных осложнений в хирургической практике, в том числе и тромбозов, нередко связана с используемым шовным материалом. Поиск новых видов шовных материалов, способных снизить риск развития послеоперационных осложнений в зоне сосудистого анастомоза, является актуальной задачей. Цель исследования – сравнительная оценка эффективности двух видов модификаций хирургического шовного материала гепарином для повышения гемосовместимости нити. Материал и методы. В настоящем исследовании использовали нить на основе полипропилена Prolene 3,0 (Ethicon, США). Ее модификацию проводили с помощью двух методик, основанных на использовании гепарина с полидиметилсилоксановым каучуком и гепарина с полигидроксибутиратом/оксивалератом. Состоятельность модифицирующего слоя и гемосовместимость оценивали методом сканирующей электронной микроскопии, спектроскопии диффузного рассеяния, гемолиза эритроцитов, адгезии и агрегации тромбоцитов. Результаты и их обсуждение. Покрытие на основе полидиметилсилоксанового каучука и гепарина располагалось неравномерно, с зонами утолщения или, наоборот, с зонами полного отсутствия покрытия. Модифицирующий слой на основе полигидроксибутирата/оксивалерата и гепарина располагался равномерно, без признаков утолщения и слущивания. Спектроскопия диффузного рассеяния подтвердила его присутствие на поверхности нити. Оценка гемосовместимости модифицированных нитей показала отсутствие гемолиза во всех исследуемых группах. Покрытие на основе полигидроксибутирата/ оксивалерата и гепарина статистически значимо снизило максимум агрегации тромбоцитов (46,28 %) относительно немодифицированной нити (82,64 %), модификация полидиметилсилоксановым каучуком и гепарином не повлияла на величину показателя (77,72 %). Количество адгезированных тромбоцитов на поверхности модифицированной полигидроксибутиратом/оксивалератом и гепарином нити было незначительным, встречались лишь единичные неактивированные формы тромбоцитов, в отличие от нити, модифицированной полидиметилсилоксановым каучуком и гепарином, на поверхности которой обнаружено большое количество адгезированных активированных тромбоцитов. Заключение. Результаты, полученные в ходе настоящего исследования, свидетельствуют о перспективности подхода в профилактике послеоперационных тромбозов путем послойной модификации хирургического шовного материала полигидроксибутиратом/оксивалератом и гепарином.</p></abstract><trans-abstract xml:lang="en"><p>Postoperative complications in surgery, including thrombosis, are often associated with the suture material. The search for new types of suture materials that reduce the risk of vascular anastomotic complications remains an urgent task. The aim of the study was to compare and evaluate the effectiveness of two types of suture materials modified with heparin in terms of the hemocompatibility. Material and methods. The study involved a thread based on the Prolene 3.0 Polypropylene Suture (Ethicon, USA) that had undergone subsequent modification. The suture was modified with either heparin with polydimethylsiloxane or heparin with polyhydroxybutyrate/oxyvalerate. The consistency and hemocompatibility of the modifying layer were evaluated by scanning electron microscopy, diffuse scattering spectroscopy, hemolysis, platelet adhesion and aggregation. Results and discussion. The modifying layer based on heparin and polydimethylsiloxane was nonhomogeneous, with either thick or completely absent coating layer. The modifying layer based on heparin and polyhydroxybutyrate/oxyvalerate was homogeneous, without signs of thickening. Diffuse reflectance spectroscopy confirmed its presence on the thread surface. Evaluation of the hemocompatibility of the modified thread revealed the absence of hemolysis in all the studied groups. The modifying layer based on heparin and polyhydroxybutyrate/ oxyvalerate significantly reduced the maximum platelet aggregation (46.28 %) compared with the unmodified thread (82.64 %), the thread modification with heparin and polydimethylsiloxane did not influence on the indicator (77.72 %). The number of platelets adhered on the surface of the thread modified with heparin and polyhydroxybutyrate/oxyvalerate was insignificant, consisting of single inactivated platelets, in contrast to a thread modified with polydimethylsiloxane rubber and heparin, on the surface of which a large number of adherent activated platelets were found. Conclusions. The results obtained indicate the promising approach for the prevention of postoperative thrombosis by layer-by-layer modification of thread with heparin and polyhydroxybutyrate/oxyvalerate.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>шовный материал</kwd><kwd>полигидроксибутират/оксивалерат</kwd><kwd>гемосовместимость</kwd><kwd>адгезия тромбоцитов</kwd><kwd>агрегация тромбоцитов</kwd><kwd>гемолиз эритроцитов</kwd><kwd>спектроскопия диффузного отражения</kwd></kwd-group><kwd-group xml:lang="en"><kwd>suture material</kwd><kwd>polyhydroxybutyrate/oxyvalerate</kwd><kwd>hemocompatibility</kwd><kwd>platelet adhesion</kwd><kwd>platelet aggregation</kwd><kwd>erythrocyte hemolysis</kwd><kwd>diffuse reflectance spectroscopy</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Работа выполнена в рамках фундаментальной темы № 0419-2022-0001 «Молекулярные, клеточные и биомеханические механизмы патогенеза сердечно-сосудистых заболеваний в разработке новых методов лечения заболеваний сердечно-сосудистой системы на основе персонифицированной фармакотерапии, внедрения малоинвазивных медицинских изделий, биоматериалов и тканеинженерных имплантатов».</funding-statement><funding-statement xml:lang="en">Тhis work was carried out within the framework of the fundamental topic No. 0419-2022-0001 “Molecular, cellular and biomechanical mechanisms of the pathogenesis of cardiovascular diseases in the development of new methods of treatment of cardiovascular diseases based on personalized pharmacotherapy, the implementation of minimally invasive medical devices, biomaterials and tissue-engineered grafts” (scientific supervisor – Academician of the RAS L.S. Barbarash).</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Wong C.Y., Vries M.R., Wang Y., Vorst J.R., Vahrmeijer A.L., Zonneveld A.J., Chaudhury P.R., Rabelink T.J., Quax P.H., Rotmans J.I. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure. J. Vasc. Surg. 2014;59(1):192– 201. doi: 10.1016/j.jvs.2013.02.242</mixed-citation><mixed-citation xml:lang="en">Wong C.Y., Vries M.R., Wang Y., Vorst J.R., Vahrmeijer A.L., Zonneveld A.J., Chaudhury P.R., Rabelink T.J., Quax P.H., Rotmans J.I. Vascular remodeling and intimal hyperplasia in a novel murine model of arteriovenous fistula failure. J. Vasc. Surg. 2014;59(1):192– 201. doi: 10.1016/j.jvs.2013.02.242</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Kearns M.C., Baker J., Myers S., Ghanem A. Towards standardization of training and practice of reconstructive microsurgery: an evidence-based recommendation for anastomosis thrombosis prophylaxis. Eur. J. Plast. Surg. 2018;41(4):379–386. doi: 10.1007/s00238-018-1417-0</mixed-citation><mixed-citation xml:lang="en">Kearns M.C., Baker J., Myers S., Ghanem A. Towards standardization of training and practice of reconstructive microsurgery: an evidence-based recommendation for anastomosis thrombosis prophylaxis. Eur. J. Plast. Surg. 2018;41(4):379–386. doi: 10.1007/s00238-018-1417-0</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Lee V.T., Tiong H.Y., Vathsala A., Madhavan K. Surgical salvage of partial pancreatic allograft thrombosis presenting as ruptured pancreatic cyst: a case report. Transplant. Proc. 2014;46(6):2019–2022. doi: 10.1016/j.transproceed.2014.05.082</mixed-citation><mixed-citation xml:lang="en">Lee V.T., Tiong H.Y., Vathsala A., Madhavan K. Surgical salvage of partial pancreatic allograft thrombosis presenting as ruptured pancreatic cyst: a case report. Transplant. Proc. 2014;46(6):2019–2022. doi: 10.1016/j.transproceed.2014.05.082</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Luong-Van E., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials. 2006;27(9):2042–2050. doi: 10.1016/j.biomaterials.2005.10.028</mixed-citation><mixed-citation xml:lang="en">Luong-Van E., Grondahl L., Chua K.N., Leong K.W., Nurcombe V., Cool S.M. Controlled release of heparin from poly(epsilon-caprolactone) electrospun fibers. Biomaterials. 2006;27(9):2042–2050. doi: 10.1016/j.biomaterials.2005.10.028</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Klopfleisch R. Macrophage reaction against biomaterials in the mouse model – Phenotypes, functions and markers. Acta Biomater. 2016;43:3–13. doi: 10.1016/j.actbio.2016.07.003</mixed-citation><mixed-citation xml:lang="en">Klopfleisch R. Macrophage reaction against biomaterials in the mouse model – Phenotypes, functions and markers. Acta Biomater. 2016;43:3–13. doi: 10.1016/j.actbio.2016.07.003</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Douglass M., Garren M., Devine R., Mondal A., Handa H. Bio-inspired hemocompatible surface modifications for biomedical applications Prog. Mater. Sci. 2022;130:100997. doi: 10.1016/j.pmatsci.2022.100997</mixed-citation><mixed-citation xml:lang="en">Douglass M., Garren M., Devine R., Mondal A., Handa H. Bio-inspired hemocompatible surface modifications for biomedical applications Prog. Mater. Sci. 2022;130:100997. doi: 10.1016/j.pmatsci.2022.100997</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Noskovicova N., Hinz B., Pakshir P. Implant fibrosis and the underappreciated role of myofibroblasts in the foreign body reaction. Cells. 2021;10(7):1794. doi: 10.3390/cells10071794</mixed-citation><mixed-citation xml:lang="en">Noskovicova N., Hinz B., Pakshir P. Implant fibrosis and the underappreciated role of myofibroblasts in the foreign body reaction. Cells. 2021;10(7):1794. doi: 10.3390/cells10071794</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Белоярцев Д.Ф., Талыблы О.Л. Отдаленные результаты эверсионной каротидной эндартерэктомии в зависимости от используемого шовного материала. Ангиол. и сосуд. хир. 2018;24(2):123–129.</mixed-citation><mixed-citation xml:lang="en">Beloyartsev D.F., Talybly O.L. Long-term results of eversion carotid endarterectomy depending on the suture material used. Angiologiya i sosudistaya khirurgiya = Angiology and Vascular Surgery. 2018;24(2):123–129. [In Russian].</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Leivo J., Virjula S., Vanhatupa S., Kartasalo K., Kreutzer J., Miettinen S., Kallio P. A durable and biocompatible ascorbic acid-based covalent coating method of polydimethylsiloxane for dynamic cell culture. J. R. Soc. Interface. 2017;14(132):20170318. doi: 10.1098/rsif.2017.0318</mixed-citation><mixed-citation xml:lang="en">Leivo J., Virjula S., Vanhatupa S., Kartasalo K., Kreutzer J., Miettinen S., Kallio P. A durable and biocompatible ascorbic acid-based covalent coating method of polydimethylsiloxane for dynamic cell culture. J. R. Soc. Interface. 2017;14(132):20170318. doi: 10.1098/rsif.2017.0318</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Акентьева Т.Н., Мухамадияров Р.А., Кривкина Е.О., Лузгарев С.В., Кудрявцева Ю.А. Экспериментальная оценка спаечного процесса в брюшной полости при использовании немодифицированного шовного материала и модифицированного гепарином. Хирургия. 2020;(3):29– 34. doi: 10.17116/hirurgia202003129</mixed-citation><mixed-citation xml:lang="en">Akentyeva T.N., Mukhamadiyarov R.A., Krivkina E.O., Luzgarev S.V., Kudryavtseva Yu.A. Influence of unmodified and modified sutures on experimental abdominal adhesive process. Khirurgiya = Surgery. 2020:(3):29–34. [in Russian]. doi: 10.17116/hirurgia202003129</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Ye X., Wang Z., Zhang X., Zhou M., Cai L. Hemocompatibility research on the micro-structure surface of a bionic heart valve. Biomed. Mater. Eng. 2014;24(6):2361–2369. doi: 10.3233/BME-141049</mixed-citation><mixed-citation xml:lang="en">Ye X., Wang Z., Zhang X., Zhou M., Cai L. Hemocompatibility research on the micro-structure surface of a bionic heart valve. Biomed. Mater. Eng. 2014;24(6):2361–2369. doi: 10.3233/BME-141049</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shen X., Su F., Dong J., Fan Z., Duan Y., Li S. In vitro biocompatibility evaluation of bioresorbable copolymers prepared from L-lactide, 1, 3-trimethylene carbonate and glycolide for cardiovascular applications. J. Biomater. Sci. Polym. Ed. 2015;26(8):497–514. doi: 10.1080/09205063.2015.1030992</mixed-citation><mixed-citation xml:lang="en">Shen X., Su F., Dong J., Fan Z., Duan Y., Li S. In vitro biocompatibility evaluation of bioresorbable copolymers prepared from L-lactide, 1, 3-trimethylene carbonate and glycolide for cardiovascular applications. J. Biomater. Sci. Polym. Ed. 2015;26(8):497–514. doi: 10.1080/09205063.2015.1030992</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Bae S., DiBalsi M.J., Meilinger N., Zhang C., Beal E., Korneva G., Brown R.O., Kornev K.G., Lee J.S. Heparin-eluting electrospun nanofiber yarns for antithrombotic vascular sutures. ACS Appl. Mater. Interfaces. 2018;10(10):8426–8435. doi: 10.1021/acsami.7b14888</mixed-citation><mixed-citation xml:lang="en">Bae S., DiBalsi M.J., Meilinger N., Zhang C., Beal E., Korneva G., Brown R.O., Kornev K.G., Lee J.S. Heparin-eluting electrospun nanofiber yarns for antithrombotic vascular sutures. ACS Appl. Mater. Interfaces. 2018;10(10):8426–8435. doi: 10.1021/acsami.7b14888</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Mohandas S.P., Balan L., Gopi J., Anoop B.S., Mohan S.P., Rosamma Ph., Cubelio S.S., Bright Singh I.S. Biocompatibility of polyhydroxybutyrate-co-hydroxyvalerate films generated from Bacillus cereus MCCB 281 for medical applications. Int. J. Biol. Macromol. 2021;176:244–252. doi: 10.1016/j.ijbiomac.2021.02.006</mixed-citation><mixed-citation xml:lang="en">Mohandas S.P., Balan L., Gopi J., Anoop B.S., Mohan S.P., Rosamma Ph., Cubelio S.S., Bright Singh I.S. Biocompatibility of polyhydroxybutyrate-co-hydroxyvalerate films generated from Bacillus cereus MCCB 281 for medical applications. Int. J. Biol. Macromol. 2021;176:244–252. doi: 10.1016/j.ijbiomac.2021.02.006</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kaniuk L., Stachewicz U. Development and advantages of biodegradable PHA polymers based on electrospun PHBV fibers for tissue engineering and other biomedical applications. ACS Biomater. Sci. Eng. 2021;7(12):5339–5362. doi: 10.1021/acsbiomaterials.1c00757</mixed-citation><mixed-citation xml:lang="en">Kaniuk L., Stachewicz U. Development and advantages of biodegradable PHA polymers based on electrospun PHBV fibers for tissue engineering and other biomedical applications. ACS Biomater. Sci. Eng. 2021;7(12):5339–5362. doi: 10.1021/acsbiomaterials.1c00757</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
